BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 34257606)

  • 21. IFI16 promotes the progression of clear cell renal cell carcinoma through the IL6/PI3K/AKT axis.
    Lu K; Zhao Y; Li Y; Fu Z; Chen Y; Kong Y; Li G
    J Transl Med; 2024 Jun; 22(1):533. PubMed ID: 38831470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selenoprotein M stimulates the proliferative and metastatic capacities of renal cell carcinoma through activating the PI3K/AKT/mTOR pathway.
    Jiang H; Shi QQ; Ge LY; Zhuang QF; Xue D; Xu HY; He XZ
    Cancer Med; 2019 Aug; 8(10):4836-4844. PubMed ID: 31274247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Klotho suppresses tumor progression via inhibiting PI3K/Akt/GSK3β/Snail signaling in renal cell carcinoma.
    Zhu Y; Xu L; Zhang J; Xu W; Liu Y; Yin H; Lv T; An H; Liu L; He H; Zhang H; Liu J; Xu J; Lin Z
    Cancer Sci; 2013 Jun; 104(6):663-71. PubMed ID: 23433103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TAGLN2 Promotes the Proliferation, Migration, Invasion, and EMT of Clear Cell Renal Cell Carcinoma Through the PI3K/Akt Signaling Pathway.
    He Y; Zhang B; Han D; Du Y; Zhang X; Wang H; Yue Z; Shang P
    Biochem Genet; 2023 Aug; 61(4):1265-1281. PubMed ID: 36547768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candidate tumor suppressor and pVHL partner Jade-1 binds and inhibits AKT in renal cell carcinoma.
    Zeng L; Bai M; Mittal AK; El-Jouni W; Zhou J; Cohen DM; Zhou MI; Cohen HT
    Cancer Res; 2013 Sep; 73(17):5371-80. PubMed ID: 23824745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
    Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
    Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KIR2DL4 promotes the proliferation of RCC cell associated with PI3K/Akt signaling activation.
    Ding XF; Chen J; Ma HL; Liang Y; Wang YF; Zhang HT; Li X; Chen G
    Life Sci; 2022 Mar; 293():120320. PubMed ID: 35063466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma.
    Weissinger D; Tagscherer KE; Macher-Göppinger S; Haferkamp A; Wagener N; Roth W
    Mol Cancer; 2013 Oct; 12(1):120. PubMed ID: 24107265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.
    Li H; Jin X; Zhang Z; Xing Y; Kong X
    Cell Biochem Funct; 2013 Jul; 31(5):427-33. PubMed ID: 23086777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Root extract of Hemsleya amabilis Diels suppresses renal cell carcinoma cell growth through inducing apoptosis and G
    Li K; You G; Jiang K; Wang R; Li W; Meng Y; Fang Y; Chen W; Zhu G; Song J; Wang W; Su H; Hu B; Sun F; Jia Z; Li C; Zhu J
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117014. PubMed ID: 37557938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
    Lin TC; Liu YP; Chan YC; Su CY; Lin YF; Hsu SL; Yang CS; Hsiao M
    J Pathol; 2015 Sep; 237(1):50-61. PubMed ID: 25925728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.
    Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR‑539 suppresses proliferation and induces apoptosis in renal cell carcinoma by targeting high mobility group A2.
    Ye ZH; Gui DW
    Mol Med Rep; 2018 Apr; 17(4):5611-5618. PubMed ID: 29436648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma.
    Chen D; Zhu M; Su H; Chen J; Xu X; Cao C
    J Cell Physiol; 2019 May; 234(5):7257-7265. PubMed ID: 30367453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TUFT1 regulates metastasis of pancreatic cancer through HIF1-Snail pathway induced epithelial-mesenchymal transition.
    Zhou B; Zhan H; Tin L; Liu S; Xu J; Dong Y; Li X; Wu L; Guo W
    Cancer Lett; 2016 Nov; 382(1):11-20. PubMed ID: 27566398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
    Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
    Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of TACC3 Inhibits the Proliferation and Invasion of Human Renal Cell Carcinoma Cells.
    Guo F; Liu Y
    Oncol Res; 2018 Mar; 26(2):183-189. PubMed ID: 28109075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TUFT1 Facilitates Metastasis, Stemness, and Vincristine Resistance in Colorectal Cancer via Activation of PI3K/AKT Pathway.
    Yang Y; Zhang T; Wu L
    Biochem Genet; 2021 Aug; 59(4):1018-1032. PubMed ID: 33634374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
    Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C
    DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FoxO transcription factors promote AKT Ser473 phosphorylation and renal tumor growth in response to pharmacologic inhibition of the PI3K-AKT pathway.
    Lin A; Piao HL; Zhuang L; Sarbassov dos D; Ma L; Gan B
    Cancer Res; 2014 Mar; 74(6):1682-93. PubMed ID: 24448243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.